Safety and Preliminary Efficacy Study of V404 PDS in Uveitis

Stopped early · Phase 1/Phase 2

Conditions studied: Uveitis, Posterior, Uveitis, Intermediate

In brief

This study is intended to evaluate the safety of V404 PDS in patients with chronic non-infectious uveitis. Secondarily, the study will evaluate whether V404 PDS can provide clinically measurable benefit over an extended period of time in patients with chronic non-infectious uveitis.

Key facts

Study ID

NCT02125266

Run by

Forsight Vision4

People needed

7

Starts

2014-04-01

Expected to finish

2015-03-01

Last updated by the study team

2016-12-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• Confirmed diagnosis of active uveitis
• Sufficient lens/media clarity
• Meet best-corrected visual acuity criteria
• Willing and able to use contraception

You may not qualify if…

• Pregnant, breast feeding
• Uncontrolled glaucoma
• Intraocular surgery or periocular/intraocular injections within 6 weeks
• Periocular or intraocular steroid within 3 months
• Prior vitrectomy
• Prior corneal transplant
• Prior fluocinolone implant
• Allergy or sensitivity to study drug
• Participation in other trial within 30 days
• Abnormal liver function
• History of positive serum tuberculosis test

Where it is running

• Study site — Golden, Colorado, United States
• Study site — Atlanta, Georgia, United States
• Study site — Omaha, Nebraska, United States
• Study site — Cleveland, Ohio, United States
• Study site — Arlington, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.